News

AddToAny

Google+ Facebook Twitter Twitter

Under the microscope: Thiomargarita magnifica

This month: Thiomargarita magnifica

What is Thiomargarita magnifica?

It is officially the world’s biggest bacterium after being discovered living on sunken, decaying mangrove tree leaves in the French Caribbean.

How big is it?

It can be as big as 1 cm in length, which is pretty big compared with the average bacterium, which is 0.002 mm long.

What does it look like?

It is visible without a microscope and is a similar size and shape to a human eyelash.

Tell me more.

To put its size in context, Jean-Marie Volland from the Joint Genome Institute at the Lawrence Berkeley National Laboratory said: “These bacteria are about 5000 times larger than most bacteria. It is the equivalent for us humans to encounter another human who would be as tall as Mount Everest.”

Should we be worried about this?

Nope, no need worry – it is not dangerous and can’t cause disease in humans.

How did this discovery come about?

It was actually first identified back in 2009 in Guadeloupe, but Dr Volland and colleagues have only recently started studying it in detail.

Where can I read more?

You can read their new paper, “A centimeter-long bacterium with DNA contained in metabolically active, membrane-bound organelles”, here – bit.ly/3ypRcel.

Image credit | Shutterstock 
 

 

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top